MITSU FST? - Suture, polyglactin Australië - Engels - Department of Health (Therapeutic Goods Administration)

mitsu fst? - suture, polyglactin

meril australia pty ltd - 17471 - suture, polyglactin - mitsu fst?is a braided coated synthetic absorbable sterile polyglactin 910 surgical suture. coated with equal parts of polyglactin 370 and calcium stearate. leads to ingrowth of fibrous connective tissue due to minimal inflammatory tissue reaction. gradual loss of tensile strength and absorbed by hydrolytic process. retains 50% tensile strength till 5 days, by 10-14 days tensile strength is completely lost. complete absorption usually by 42 days. intended for use where only short term wound support is required and also where the rapid absorption of the suture is desirable. the rapid absorption profile is particularly useful for applications such as skin closure including episiotomy repair, circumcision, pediatric surgery, closure of oral mucosa and in ophthalmic surgery for conjunctivas sutures.

FILAXYN?  - Suture, polydioxanone Australië - Engels - Department of Health (Therapeutic Goods Administration)

filaxyn? - suture, polydioxanone

meril australia pty ltd - 16584 - suture, polydioxanone - sterile, synthetic absorbable monofilament suture composed of poly (p-dioxanone) attached to standard stainless steel needles. leads to ingrowth of fibrous connective tissue due to minimal initial inflammatory tissue reaction. it gradually loses tensile strength and is finally absorbed by hydrolytic process. 70% tensile strength retained until 14 days, 50%-60% retained until 28 days. complete absorption usually takes place between 180-220 days. intended for use in general soft tissue approximation including use in pediatric cardiovascular tissue, microsurgery and ophthalmic surgery. these sutures are particularly useful where an absorbable suture with prolonged wound support (up to 42 days) is required.

CHLORTHALIDONE tablet Verenigde Staten - Engels - NLM (National Library of Medicine)

chlorthalidone tablet

nucare pharmaceuticals,inc. - chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. chlorthalidone is indicated in pregnancy when edema is due to

Silk suture, sterile Australië - Engels - Department of Health (Therapeutic Goods Administration)

silk suture, sterile

meril australia pty ltd - 13910 - silk suture, sterile - intended for use as non-absorbable sutures in general soft tissue approximation and/or ligation including use in ophthalmic.

CHLORTHALIDONE tablet Verenigde Staten - Engels - NLM (National Library of Medicine)

chlorthalidone tablet

denton pharma, inc. dba northwind pharmaceuticals - chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. chlorthalidone is indicated in pregnancy when edema is due to

CHLORTHALIDONE tablet Verenigde Staten - Engels - NLM (National Library of Medicine)

chlorthalidone tablet

denton pharma, inc. dba northwind pharmaceuticals - chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. chlorthalidone is indicated in pregnancy when edema is due to

CHLORTHALIDONE tablet Verenigde Staten - Engels - NLM (National Library of Medicine)

chlorthalidone tablet

proficient rx lp - chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. chlorthalidone is indicated in pregnancy when edema is due to

SYNERRV SOLIFENACIN SUCCINATE FILM-COATED TABLETS 5MG Singapore - Engels - HSA (Health Sciences Authority)

synerrv solifenacin succinate film-coated tablets 5mg

synerrv (s) pte. ltd. - solifenacin succinate - tablet, film coated - solifenacin succinate 5.0mg

FILAPRON? - Suture, polydioxanone Australië - Engels - Department of Health (Therapeutic Goods Administration)

filapron? - suture, polydioxanone

meril australia pty ltd - 16584 - suture, polydioxanone - sterile, synthetic absorbable monofilament suture attached to standard stainless-steel needles. available undyed clear and dyed violet to enhance visibility in tissue. leads to ingrowth of fibrous connective tissue due to minimal initial inflammatory tissue reaction. it gradually loses tensile strength and is absorbed by hydrolytic process. complete absorption usually takes place between 90 to 120 days. intended for use in general approximation and/or ligation of soft tissues where an absorbable material is indicated.

Fixation nail, intramedullary, arthrodesis Australië - Engels - Department of Health (Therapeutic Goods Administration)

fixation nail, intramedullary, arthrodesis

meril australia pty ltd - 44854 - fixation nail, intramedullary, arthrodesis - intramedullary nail is intended for the fixation of long bone fractures, including diaphyseal fractures in the humerus, tibia and femur. it is indicated for shaft fractures 5cm below the surgical neck, and 5 cm proximal to the distal end of the medullary canal.